Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;37(4):843-848.
doi: 10.1007/s00467-021-05290-7. Epub 2021 Sep 25.

Seroprotection against measles in previously vaccinated children with difficult-to-treat nephrotic syndrome

Affiliations

Seroprotection against measles in previously vaccinated children with difficult-to-treat nephrotic syndrome

Jiten Kumar Sahoo et al. Pediatr Nephrol. 2022 Apr.

Abstract

Background: Children with nephrotic syndrome (NS) are vulnerable to infections. Measles infection is an important cause of morbidity and mortality in immunosuppressed children. A suboptimal seroprotection against measles has been shown in immunocompromised children. There is limited published literature on measles immunity in children with difficult-to-treat nephrotic syndrome (DTNS). We compared the proportions of children with DTNS and healthy controls who were seroprotected against measles.

Methods: This was a cross-sectional study. Measles-specific IgG antibodies of 108 children with DTNS (3 to 10 years of age) and an equal number of age-matched healthy controls were measured. All children had received two doses of measles-containing vaccine at 9-12 and 16-24 months of age under routine immunisation programme. Serum measles IgG antibody titres were measured by indirect ELISA. The assay results were interpreted as (1) > 11 NTU (NovaTec Units), positive/seroprotective titres; (2) 9-11, equivocal; and (3) < 9 NTU, negative. Inter- and intra-group comparisons were made to identify the disease characteristics related to seroprotection status.

Results: The proportion of children with protective anti-measles antibodies (n = 70, 65%) was significantly lower in DTNS as compared to controls (n = 88, 81.48%) (p = 0.005). Their median [IQR] antibody titres were also significantly lower than those in controls (14.1 [14] NTU vs. 18.3 [15.2] NTU (p = 0.001). The age, gender, clinical subtype, duration of disease, and type of immunosuppressive therapy were not significantly different between seroprotected and non-seroprotected children with DTNS.

Conclusion: A significantly lower percentage of fully vaccinated children with DTNS were seroprotected against measles compared to healthy controls. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keywords: Measles; Seroprotection; Steroid-resistant nephrotic syndrome; Steroid-sensitive nephrotic syndrome.

PubMed Disclaimer

References

    1. Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M (2013) Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome? J Trop Pediatr 59:343–349 - DOI
    1. Alwadhi RK, Mathew JL, Rath B (2004) Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health 40:28–32 - DOI
    1. Alfakeekh K, Azar M, Sowailmi BA, Alsulaiman S, Makdob SA, Omair A et al (2019) Immunosuppressive burden and risk factors of infection in primary childhood nephrotic syndrome. J Infect Public Health 12:90–94 - DOI
    1. Gulati S, Kher V, Gupta A, Arora P, Rai PK, Sharma RK (1995) Spectrum of infections in Indian children with nephrotic syndrome. Pediatr Nephrol 9:431–434 - DOI
    1. Patel MK, Goodson JL, Alexander JP Jr et al (2020) Progress toward regional measles elimination – Worldwide, 2000–2019. MMWR Morb Mortal Wkly Rep 69:1700–1705 - DOI

Substances

LinkOut - more resources